Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation
. 2021; 
Frequency ofBRCA1andBRCA2Germline Mutations Detected by Protein Truncation Test and Cumulative Risks of Breast and Ovarian Cancer among Mutation Carriers in Japanese Breast Cancer Families
Journal of Korean Breast Cancer Society. 2002;5(3):194
Breast Cancer Gene, BRCA1 and BRCA2
Journal of Korean Breast Cancer Society. 2003;6(2):45
Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study
Breast Cancer: Targets and Therapy. 2023;Volume 15:671-682
EP-1832: Heterozygous germline mutation in NBS1 among Non-BRCA1/2 Korean patients with high-risk breast cancer
Radiotherapy and Oncology. 2014;111:S300
An 8-lncRNA signature predicts the survival of triple-negative breast cancer patients without germline BRCA1/2 mutation
. 2021;
P7 The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation
The Breast. 2007;16:S14
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
Breast Cancer: Targets and Therapy. 2023;Volume 15:163-173
Germline 657del5 mutation in the NBS1 gene in breast cancer patients
International Journal of Cancer. 2003;106(3):379-381
An 8-lncRNA Signature Predicts Survival of Triple-Negative Breast Cancer Patients Without Germline BRCA1/2 Mutation
. 2020;